UGT1A1 and Decreased total neutrophil count: Today, a genetic test for UGT1A1, especially the UGT1A1*6 and UGT1A1*28 mutations, is performed before treatment with CPT-11, because use of CPT-11 carries a high risk of adverse effects such as severe neutropenia and diarrhea [12].